Summary
A crossover comparison of metoprolol and hydrochlorothiazide has been performed in 20 patients with mild hypertension. Both drugs caused almost identical statistically significant reduction in blood pressure of about 20 mm Hg systolic and 15 mm Hg diastolic. The side effects during active therapy were few and mild, but 5 patients experienced subjective symptoms during the first few days following abrupt withdrawal of metoprolol, namely general malaise, palpitations, headache, sweating and tremor. The symptoms were more pronounced in the standing postition and disappeared at once on resumption of β-blocker therapy, or gradually over 5 – 7 days when placebo tablets were given. In 11 of the 20 patients hydrochlorothiazide produced subnormal serum potassium levels and potassium supplements were given. The serum uric acid level was also significantly increased during hydrochlorothiazide treatment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Åblad, B., Carlsson, E., Ek, L.: Pharmacological studies of two new cardioselective adrenergic beta-receptor antagonists. Life Sci.12, 107–119 (1973)
Alderman, E.L., Coltart, D.J., Wettach, G.E., Harrison, D.C.: Coronary artery syndromes after sudden propranolol withdrawal. Ann. intern. Med.81, 625–627 (1974)
Bengtsson, C.: Comparison between alprenolol and chlorthalidone as antihypertensive agents. Acta med. scand.191, 433–439 (1972a)
Bengtsson, C.: Comparison between alprenolol and propranolol as antihypertensive agents. Acta med. scand.192, 415–418 (1972b)
Bengtsson, C.: Long-term effect of alprenolol as antihypertensive agent. Acta med. scand.554 (Suppl.), 9–14 (1974)
Bengtsson, C.: The effect of metoprolol — a new selective adrenergic beta1-receptor blocking agent — in mild hypertension. Acta med. scand.199, 65–70 (1976)
Degnbol, B., Dorph, S., Marner, T.: The effect of different diuretics on elevated blood pressure and serum potassium. Acta med. scand.193, 407–410 (1973)
Galbo, H., Trap-Jensen, J., Christensen, N.J.: Personal communication
Jäättelä, A., Pyörälä, K.: A controlled study on the antihypertensive effect of a new beta adrenergic blocking drug, metoprolol, in combination with chlorthalidone. Brit.J.clin. Pharmacol. (Accepted for publication)
Miller, R.R., Olson, H.G., Amsterdam, E.A., Mason, D.T.: Propranolol-withdrawal rebound phenomenon. New Engl. J. Med.293, 416–418 (1975)
Muckadell, O.B.S., Gyntelberg, F.: The antihypertensive effect of a new beta-blocking agent pindolol compared with chlorthalidone. Europ. J. clin. Pharmacol.5, 210–213 (1973)
O'Brien, E.T., McKinnon, J.: Propranolol and polythiazide in treatment of hypertension. Brit. Heart J.34, 1042–1044 (1972)
Pedersen, O.L.: Metoprolol, en ny cardioselectiv betablokker anvendt i behandlingen af arteriel hypertension. Ugeskr. Laeg.137, 2274–2276 (1975)
Stokkeland, O.M., Sangvik, K., Lindseth Ditlefsen, E.-M.: A comparative study of metoprolol and trichlormethiazide in hypertension. Current ther. Res.18, 755–768 (1975)
Tibblin, G., Åblad, B.: Antihypertensive therapy with alprenolol, a β-adrenergic receptor antagonist. Acta med. scand.186, 451–457 (1969)
Wilkinson, P.R., Issler, H., Hesp, R., Raftery, E.B.: Total body and serum potassium during prolonged thiazide therapy for essential hypertension. Lancet1975 I, 759–762
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lederballe Pedersen, O. Comparison of metoprolol and hydrochlorothiazide as antihypertensive agents. Eur J Clin Pharmacol 10, 381–385 (1976). https://doi.org/10.1007/BF00563073
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00563073